HIGH EFFICACY OF ABT-493 AND ABT-530 IN HCV GENOTYPE 1-INFECTED PATIENTS WHO HAVE FAILED DIRECT-ACTING ANTIVIRAL-CONTAINING REGIMENS: THE MAGELLAN-I STUDY

Press/Media: Press / Media

PeriodApr 15 2016

Media coverage

1

Media coverage

  • TitleHIGH EFFICACY OF ABT-493 AND ABT-530 IN HCV GENOTYPE 1-INFECTED PATIENTS WHO HAVE FAILED DIRECT-ACTING ANTIVIRAL-CONTAINING REGIMENS: THE MAGELLAN-I STUDY
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/15/16
    PersonsFred Poordad